John J. Kerrigan

A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues

Lata T. Gooljarsingh, Christine Fernandes, Kang Yan et al. · Proceedings of the National Academy of Sciences · 2006 · 119 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Discovery of Substituted Maleimides as Liver X Receptor Agonists and Determination of a Ligand-Bound Crystal Structure

Michael Jaye, John A. Krawiec, Nino Campobasso et al. · Journal of Medicinal Chemistry · 2005 · 58 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Suppressing Posttranslational Gluconoylation of Heterologous Proteins by Metabolic Engineering of <i>Escherichia coli</i>

Juan C. Aon, Richard J. Caimi, Alexander H. Taylor et al. · Applied and Environmental Microbiology · 2007 · 48 citations

Life Sciences, Biochemistry, Biotechnology +16

Design, Synthesis, and Properties of a Potent Inhibitor of<i>Pseudomonas aeruginosa</i>Deacetylase LpxC

Grazia Piizzi, David T. Parker, Yunshan Peng et al. · Journal of Medicinal Chemistry · 2017 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Optimized procedures for producing biologically active chemokines

Quinn Lu, Matthew Burns, Patrick McDevitt et al. · Protein Expression and Purification · 2009 · 22 citations

Pharmacy, Pharmaceutical Biotechnology, Drug Discovery +3